COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 2123: Articles 21221-21230  | Next

Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use
Shen, M., Zu, J., Fairley, C. K., Pagan, J. A., An, L., Du, Z., Guo, Y., Rong, L., Xiao, Y., Zhuang, G., Li, Y., Zhang, L.
10.1101/2020.10.28.20221234 — Posted: 2020-10-30
Pre-existing conditions are associated with long-COVID patients hospitalization, despite confirmed clearance of SARS-CoV-2 virus
Pawlowski, C., Venkatakrishnan, A., Ramudu, E., Kirkup, C., Puranik, A., Kayal, N., Berner, G., Anand, A., Barve, R., O'Horo, J. C., Badley, A. D., Soundararajan, V.
10.1101/2020.10.28.20221655 — Posted: 2020-10-30
Projecting the impact of behaviour and isolation interventions and super spreader events from mass gatherings and international travel on Malaysia's COVID-19 epidemic trajectories using an augmented SEIR model
Ayub, A. J., Ho, G. W. S., Mohd Hanafiah, K.
10.1101/2020.10.29.20222224 — Posted: 2020-10-30
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Ogega, C. O., Skinner, N. E., Blair, P. W., Park, H.-S., Littlefield, K., Ganesan, A., Ladiwala, P., Antar, A. A., Ray, S. C., Betenbaugh, M. J., Pekosz, A., Klein, S., Manabe, Y. C., Cox, A. L., Bailey, J. R.
10.1101/2020.10.28.20220996 — Posted: 2020-10-30 Discussion: Offsite
COVID-19 collateral: Indirect acute effects of the pandemic on physical and mental health in the UK
Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A., Carreira, H., Matthews, A. A., Bidulka, P., Gayle, A., Forbes, H., Cook, S., Wong, A., Strongman, H., Wing, K., Warren-Gash, C., Cadogan, S. L., Smeeth, L., Hayes, J., Quint, J., McKee, M., Langan, S.
10.1101/2020.10.29.20222174 — Posted: 2020-10-30
Understanding and addressing challenges for Advance Care Planning in the COVID-19 pandemic: An analysis of the UK CovPall survey data from specialist palliative care services.
Bradshaw, A., Dunleavy, L., Walshe, C., Preston, N., Cripps, R., Hocaoglu, M., Bajwah, S., Maddocks, M., Oluyase, A., Sleeman, K., Higginson, I., Fraser, L., Murtagh, F.
10.1101/2020.10.28.20200725 — Posted: 2020-10-30
Modeling the Opening SARS-CoV-2 Spike: an Investigation of its Dynamic Electro-Geometric Properties
Kucherova, A., Strango, S., Sukenik, S., Theillard, M.
10.1101/2020.10.29.361261 — Posted: 2020-10-29
COVID-19 cytokines and the hyperactive immune response: Synergism of TNF-α and IFN-γ in triggering inflammation, tissue damage, and death
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., Schreiner, P., Neale, G., Vogel, P., Webby, R., Jonsson, C. B., Kanneganti, T.-D.
10.1101/2020.10.29.361048 — Posted: 2020-10-29 Discussion: Onsite | Offsite
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID 19
Saris, A., Reijnders, T. D., Nossent, E. J., Schuurman, A. R., Verhoeff, J., van Asten, S. D., Bontkes, H. J., Blok, S. G., Duitman, J., Bogaard, H. J., Heunks, L., Lutter, R., van der Poll, T., Garcia Vallejo, J. J.
10.1101/2020.10.29.360586 — Posted: 2020-10-29
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response and cross-reactivity with endemic HCoVs
Stoddard, C. I., Galloway, J., Chu, H. Y., Shipley, M. M., Itell, H. L., Wolf, C. R., Logue, J. K., Magedson, A., Sung, K., Garrett, M., Crawford, K. H., Laserson, U., Matsen, F. A., Overbaugh, J.
10.1101/2020.10.29.360800 — Posted: 2020-10-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).